Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVE Study
NCT04470427Phase 3Completed
- Sponsor
- Moderna Inc
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Moderna Inc. Started Jul 2020; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04470427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470427.